Bryan J McMichael insider trades
Open-market stock purchases and sales by Bryan J McMichael, Chief Financial Officer at Coherus Oncology, Inc, from SEC Form 4 filings since Sep 7, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 29, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $1.5M |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $162K |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $163K |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $150K |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | $159K |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | $39.8K |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | $23.9K |
| May 29, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | $47.7K |
| Jan 22, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | — |
| Jan 22, 2026 | CHRS Coherus Oncology, Inc | Bought (not open market) | — |
| Jan 20, 2026 | CHRS Coherus Oncology, Inc | Sold (not open market) | $2.7K |
Companies traded
- CHRS Coherus Oncology, Inc: other filings, last May 29, 2026